Clinical and immune modulating effects of casein glycomacropeptide on healthy adults and patients with ulcerative colitis.
12.05.2020 | Health Kommunikation
Dato | fre 15 maj |
Tid | 14:30 — 16:30 |
Sted | Auditorium J116-113 |
Fredag den 15. maj kl. 14.30 forsvarer Pernille Glahn Wernlund sin Ph.d.-afhandling med titlen: “Clinical and immune modulating effects of casein glycomacropeptide on healthy adults and patients with ulcerative colitis.”
Forsvaret er offentligt og finder sted i Auditorium J116-113.